FDA’s Shuren On Why Agency Broke Up Its IVD And Radiological Health Office

The US FDA split its Office of In Vitro Diagnostics and Radiological Health in two earlier this week because it “really had two flavors of technology – actually three – that sat in there,” says Jeff Shuren, director of the agency’s device center.

The chain with arrows splits into two.
• Source: Shutterstock

More from Regulation

More from Policy & Regulation